Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code: 01276) reported that authorized share capital remained at RMB 6,637,199,874 as of October 31, 2025, with 258,197,600 H shares and 6,379,002,274 A shares authorized. During the period, issued H shares remained at 258,197,600, while issued A shares decreased from 6,366,078,564 to 6,362,732,164.

The number of treasury shares increased from 12,923,710 to 16,270,110, stemming from the repurchase of 3,346,400 A shares in October for future use under the company’s A Share Employee Stock Ownership Schemes. Repurchase prices ranged from RMB 63.23 to RMB 69.33 per share, contributing to the overall 3,346,400-share reduction in the company’s issued A shares and equivalent rise in treasury shares. These developments reflect continued execution of the employee incentive programs outlined in earlier shareholder documents.